An international expert panel, active within the European Society for Blood and Marrow
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group, and …

The acquired von Willebrand syndrome (AVWS) is a bleeding disorder that is frequently
unrecognized or is misdiagnosed as von Willebrand disease. AVWS is characterized by …

Opinion statement Relapse is still a common scenario in acute myeloid leukemia (AML)
treatment and occurs in 40–50% of younger and the great majority of elderly patients. The …

Background Recent studies have provided a detailed census of genes that are mutated in
acute myeloid leukemia (AML). Our next challenge is to understand how this genetic diversity …

Background Mutations occur in several genes in cytogenetically normal acute myeloid
leukemia (AML) cells: the nucleophosmin gene (NPM1), the fms-related tyrosine kinase 3 gene (…

Background All-trans retinoic acid (ATRA) with chemotherapy is the standard of care for
acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of …

Background Emerging evidence suggests that stem cells and progenitor cells derived from
bone marrow can be used to improve cardiac function in patients after acute myocardial …

Background— Intracoronary transfer of autologous bone marrow cells (BMCs) may enhance
recovery of left ventricular (LV) function in patients after acute myocardial infarction (AMI). …

Background Whether it is possible to reduce the intensity of treatment in early (stage I or II)
Hodgkin's lymphoma with a favorable prognosis remains unclear. We therefore conducted a …

Background— Intracoronary transfer of autologous bone marrow cells (BMCs) promotes
recovery of left ventricular systolic function in patients with acute myocardial infarction. Although …